XORTX Therapeutics Inc. - Common Shares (XRTX) analyst actions
Rating and price-target actions on XRTX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the XRTX overview →
3 measured XRTX analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™ | Press release | -0.83% | -3.32% | |
| XORTX Initiates IND Preparation for XORLO™ in Gout Program | Press release | +0.00% | +4.86% | |
| XORTX Initiates Precision Medicine Program | Press release | -2.21% | -6.08% |
Keep exploring
More XRTX: earnings → · SEC filings → · XRTX overview →